Brexit won. Futures down 4 percent. UK futures down 7 percent. Perception will always trump the truth in the short term. BP will see a 2 handle tomorrow.
Hey Billy, what's another $30 mil loss today between friends?
He was praising VRX a year ago at $240. What does he know? He likes anything in an uptrend and sells anything in a downtrend. Then he spins tales about it on CNBC. He adds zero value to my trading decisions.
So using VRX updated earnings outlook, it's now trading at a remarkable and unsustainably low 3.6 PE!! Now that is ridiculous. If Pearson was still in control, I could understand why investors would have no faith in a Company run by the absolutely worst CEO of modern times. But Papa has a good reputation. The issues are pretty much known now. The debt is high but not due for a while. There are products which cash flow nicely. So why the sell off? Seems like just some shortsellers piling on.
Why is ESV trailing RIG by such a huge gap? It looks to be about 16% behind. ESV should be over $12 compared to RIG. ESV is a much better run company, with less debt and more backlog. Any thoughts?
Don't pay attention to the paid bashers on this Board. If FDA wanted to reject SRPT drug, they would have already. The 30% shlacking on the FDA update yesterday is not reasonable. Read the Barron's (surprisingly positive) note today.
ICPT liver drug, Ocaliva, was already approved for fast-track approval 6 weeks ago. What do you think the chances are for FDA to approve fast-track approval and then deny approval subsequenty? Kinda doesn't make sense even with the current mental midgets on the FDA panel. So the smart money has already priced that in, hence the lack of trading excitement. The real question is if Ocaliva can be approved for NASH. A decision which will probably not be made until 2018. So everyone stay calm and stop overanalyzing every tick.
It does - dozens of drugs in clinical stages. Good article posted today by Motley Fool. Read it.
XON is so much more than Zika. Unfortunately CNBC keeps pumping the Zika angle. With a little DD one can see the huge potential of XON and it's synthetic bio products. Zika is only about 0.1% of the story here. Let's all get over it.
This company is still way overvalued. Talk to me about investing in it when it starts to show a profit. No such thing even in sight.
Talk about beating a dead horse! I mean even Andrew Left is saying VRX is a good long here.